Vendor, Pittsburgh, PA
Magee-Womens Research Institute and Foundation
UEI J3Z5MNJJ3FZ4, CAGE 3C8Z7
2 awards and $134,901 obligated between July 31, 2024 and August 1, 2025, 100% under full and open competition, against 17.0 offers on average where reported.
Industries
NAICS on the awards, by dollars.
| Research and Development in Biotechnology (except Nanobiotechnology)NAICS 541714 | $134,901 |
How it wins
Awards by competition, set-aside and type.
| Full and Open Competition | 2 |
| Delivery Order | 2 |
Awards
Every award in the window, by dollars obligated.
| Contract | Awarding office | Described as | Obligated |
|---|---|---|---|
| 75N94023F00001Delivery Order, September 26, 2024, Full and Open Competition, 16 offers | National Institutes of Health NichdNational Institutes of Health | 75n94020d00018/75n94023f00001 - Ovaprene Vaginal Device Clinical Trial - Magee Womens Research Institute and Foundation - FY22 Can 8054183NAICS 541714, PSC AN12 | $114,629 |
| 75N94020F00001Delivery Order, July 31, 2024, Full and Open Competition, 18 offers | National Institutes of Health NichdNational Institutes of Health | 75n94020d00018/75n94020f00001-Core Functions Activities to Provide Assistance in Protocol Review, Protocol Development, and Activities AssocNAICS 541714, PSC AN12 | $20,272 |
- Places of performance
- Pennsylvania
- Product and service codes
- AN12 Health R&D Services; Health Care Services; Applied Research
- Transactions
- 5 across 2 awards